Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host.

Autor:	Winston DJ; Division of Hematology-Oncology, Department of Medicine, Center for Health Sciences, University of California, Los Angeles (UCLA), Los Angeles, California, USA., Young PA; Division of Hematology-Oncology, Department of Medicine, Center for Health Sciences, University of California, Los Angeles (UCLA), Los Angeles, California, USA., Schlamm HT; H. T. S. Pharma Consulting, San Diego, California, USA., Schiller GJ; Division of Hematology-Oncology, Department of Medicine, Center for Health Sciences, University of California, Los Angeles (UCLA), Los Angeles, California, USA.
Jazyk:	angličtina
Zdroj:	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 16; Vol. 79 (2), pp. 572.
DOI:	10.1093/cid/ciad769
Abstrakt:	Competing Interests: Potential conflicts of interest. H. T. S. reports a position as paid consultant to Pfizer but did not receive any financial support for the preparation of this manuscript. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu